top of page
A breakthrough treatment for heart failure
Designed to address a significant unmet medical need in heart failure, the BAROSTIM NEO was one of the first therapies to receive the FDA’s coveted Breakthrough Device Designation. This distinction is reserved for unique therapies that are intended to treat a life-threatening or irreversibly debilitating disease where there is no available treatment alternative. BAROSTIM NEO is now offered in Arizona by IronRod Health
Barostim Neo CVRx
BAROSTIM NEO is designed to electrically activate the baroreflex, the body’s main cardiovascular reflex, signaling the brain to regulate cardiovascular function. BAROSTIM THERAPY activates baroreceptors in the wall of the carotid artery and stimulates the afferent and efferent pathways of the autonomic nervous system. The brain responds to the therapy by modulating efferent pathways, to relax blood vessels, slow the heart rate and reduce fluid in the body via improved kidney function.
bottom of page